Mutations in the gene encoding the 3′-5′ DNA exonuclease TREX1 are associated with systemic lupus erythematosus
The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
TREX1 acts in concert with the SET complex in granzyme A-mediated apoptosis, and mutations in TREX1 cause Aicardi-Goutières syndrome and familial chilblain lupus. Here, we report monoallelic frameshift or missense mutations and one 3' UTR variant of TREX1 present in 9/417 individuals with systemic lupus erythematosus but absent in 1,712 controls (P = 4.1 x 10(-7)). We demonstrate that two mutant TREX1 alleles alter subcellular targeting. Our findings implicate TREX1 in the pathogenesis of SLE.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“TREX1 mutations have been identified in SLE115 and familial chilblain lupus116, implicating TREX1 as a safeguard against autoimmune inflammation.”
From The role of retrotransposable elements in ageing and age-associated diseases (2021) · cites this paper as [115]
Citations
Cites
Recognition of Cytosolic DNA Activates an IRF3-Dependent Innate Immune Response
Stetson, D. B., & Medzhitov, R. (2006) · Immunity · doi:10.1016/j.immuni.2005.12.003 · Cited by 1,008
Crow, Y. J., Hayward, B. E., Parmar, R., Robins, P., Leitch, A., Ali, M., Black, D. N., van Bokhoven, H., Brunner, H. G., Hamel, B. C., et al. (2006) · Nature Genetics · doi:10.1038/ng1845 · Cited by 903
Features of systemic lupus erythematosus in Dnase1-deficient mice
Napirei, M., Karsunky, H., Zevnik, B., Stephan, H., Mannherz, H. G., & Möröy, T. (2000) · Nature Genetics · doi:10.1038/76032 · Cited by 789
Mutation of DNASE1 in people with systemic lupus erythematosus
Yasutomo, K., Horiuchi, T., Kagami, S., Tsukamoto, H., Hashimura, C., Urushihara, M., & Kuroda, Y. (2001) · Nature Genetics · doi:10.1038/91070 · Cited by 596
Chronic polyarthritis caused by mammalian DNA that escapes from degradation in macrophages
Kawane, K., Ohtani, M., Miwa, K., Kizawa, T., Kanbara, Y., Yoshioka, Y., Yoshikawa, H., & Nagata, S. (2006) · Nature · doi:10.1038/nature05245 · Cited by 470
Rice, G., Newman, W. G., Dean, J., Patrick, T., Parmar, R., Flintoff, K., Robins, P., Harvey, S., Hollis, T., O’Hara, A., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/513443 · Cited by 410
Self-citationMorita, M., Stamp, G., Robins, P., Dulic, A., Rosewell, I., Hrivnak, G., Daly, G., Lindahl, T., & Barnes, D. E. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.15.6719-6727.2004 · Cited by 380
Mendell, J. T., & Dietz, H. C. (2001) · Cell · doi:10.1016/s0092-8674(01)00583-9 · Cited by 289
Role and fate of PML nuclear bodies in response to interferon and viral infections
Regad, T., & Chelbi-Alix, M. K. (2001) · Oncogene · doi:10.1038/sj.onc.1204854 · Cited by 281
Mazur, D. J., & Perrino, F. W. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.28.19655 · Cited by 276
Self-citation
Cited by
Items 301–400 of 728
Khatib, I. A., Deng, J., Lei, Y., Torres-Odio, S., Rojas, G. R., Newman, L. E., Chung, B. K., Symes, A., Zhang, H., Huang, S.-Y. N., et al. (2023) · Human Molecular Genetics · doi:10.1093/hmg/ddad062 · Cited by 43
Targeting of the immune system in systemic lupus erythematosus
Ramanujam, M., & Davidson, A. (2008) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399408000562 · Cited by 40
WEISENBURGER, T. H., von Neubeck, B., Schneider, A. M., Ebert, N., Schreyer, D., Acs, A., & Winkler, T. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01551 · Cited by 42
“Homozygous mutations in the TREX1 gene encoding a DNA exonuclease present in the cytoplasm are associated with the Aicardi–Goutieres syndrome-1 with increased systemic type I interferon levels and antinuclear autoantibodies (10).”
Giaglis, S., Daoudlarian, D., Voll, R. E., Kyburz, D., Venhoff, N., & Walker, U. A. (2021) · RMD Open · doi:10.1136/rmdopen-2021-002010 · Cited by 44
Medicinal chemistry perspective on cGAS-STING signaling pathway with small molecule inhibitors
Tian, X., Xu, F., Zhu, Q., Feng, Z., Dai, W., Zhou, Y.-L., You, Q., & Xu, X. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114791 · Cited by 44
TREX1 acts in degrading damaged DNA from drug-treated tumor cells
Wang, C.-J., Lam, W., Bussom, S., Chang, H.-M., & Cheng, Y. (2009) · DNA repair · doi:10.1016/j.dnarep.2009.06.006 · Cited by 36
“Dominant mutations in human TREX1 gene mapped to chromosome 3p21 are linked to the development of autoimmune diseases including: (i) Aicardi-Goutières syndrome (AGS) [11– 13], a severe neurological brain disease mimicking congenital viral infection with the features of demyelination and calcification of the basal gang…”
BackgroundTyping TREX1 gene in patients with systemic lupus erythematosus
Fredi, M., Bianchi, M., Andréoli, L., Greco, G., Olivieri, I., Orcesi, S., Fazzi, E. M., Cereda, C., & Tincani, A. (2015) · Reumatismo · doi:10.4081/reumatismo.2015.782 · Cited by 46
Rare Variants in theTREX1Gene and Susceptibility to Autoimmune Diseases
Barizzone, N., Monti, S. M., Mellone, S., Godi, M., Marchini, M., Scorza, R., Danieli, M. G., & D’Alfonso, S. (2013) · BioMed Research International · doi:10.1155/2013/471703 · Cited by 36
Changes in the biochemical taste of cytoplasmic and cell-free DNA are major fuels for inflamm-aging
Storci, G., Carolis, S. D., Olivieri, F., & Bonafè, M. (2018) · Seminars in Immunology · doi:10.1016/j.smim.2018.08.003 · Cited by 38
Structural basis for RNA trimming by RNase T in stable RNA 3′-end maturation
Hsiao, Y.-Y., Yang, C. C., Lin, C., Lin, J. L. J., Duh, Y., & Yuan, H. S. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.524 · Cited by 37
“and TREX1 in Aicardi-Goutieres syndrome and familial chilblain lupu”
BackgroundRNaseH2 mutants that cause Aicardi–Goutieres syndrome are active nucleases
Perrino, F. W., Harvey, S., Shaban, N. M., & Hollis, T. (2009) · Journal of Molecular Medicine · doi:10.1007/s00109-008-0422-3 · Cited by 35
“We recently described the effects of TREX1 mutations found in autoimmune diseases on the 3′→5′ deoxyribonuclease activities of this enzyme, illustrating the challenges in correlating human genetic mutations to functional consequences in the encoded enzyme [10, 11, 15, 16, 21].”
Self-citationZaid, A. K. M. A., & Ariel, A. (2024) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2024.115204 · Cited by 36
Gaining a foothold: how HIV avoids innate immune recognition
Yan, N., & Lieberman, J. (2010) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.11.004 · Cited by 44
Self-citationInnate immune processes in lupus erythematosus
Aringer, M., Günther, C., & Lee‐Kirsch, M. A. (2012) · Clinical Immunology · doi:10.1016/j.clim.2012.11.012 · Cited by 37
Self-citationRole of Cytokines in Systemic Lupus Erythematosus: Recent Progress from GWAS and Sequencing
Connolly, J. J., & Hakonarson, H. H. (2012) · BioMed Research International · doi:10.1155/2012/798924 · Cited by 38
“, single gene defect) SLE [154, 155] and may be an instructive vehicle by which to explore the application of”
BackgroundTomicic, M. T., Aasland, D., Nikolova, T., Kaina, B., & Christmann, M. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.03.029 · Cited by 35
Vogt, J., Agrawal, S., Ibrahim, Z., Southwood, T. R., Philip, S., MacPherson, L. K. R., Bhole, M. V., Crow, Y. J., & Oley, C. (2013) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.35712 · Cited by 39
“Interestingly, heterozygous TREX1mutations have also been identified in approximately 2% of those affected with the non-syndromic form of the autoimmune condition systemic lupus erythematosus [Lee-Kirsch et al., 2007], emphasizing the role of these genes in immune regulation.”
BackgroundHomeostatic Milieu Induces Production of Deoxyribonuclease 1–like 3 from Myeloid Cells
Inokuchi, S., Mitoma, H., Kawano, S., Nakano, S., Ayano, M., Kimoto, Y., Akahoshi, M., Arinobu, Y., Tsukamoto, H., Akashi, K., et al. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1901304 · Cited by 35
Du, H., Xiao, N., Zhang, S., Zhou, X., Zhang, Y., Lu, Z., Fu, Y., Huang, M., Xu, S., & Chen, Q. (2023) · iScience · doi:10.1016/j.isci.2023.107090 · Cited by 35
“In clinical research, TREX1 gene mutations have been associated with a variety of autoimmune diseases or type I interferonopathies, and Trex1 knockout mice also show a variety of lupus-like disease phenotypes.(24,25) Currently, JAK1/2 inhibitors are used clinically to treat autoimmune diseases or type I interferonopat…”
BackgroundProcessing of nonconventional DNA strand break ends
Wilson, D. M. (2007) · Environmental and Molecular Mutagenesis · doi:10.1002/em.20346 · Cited by 36
“Studies have also implicated functionally disruptive mutations in TREX1 in the pathogenesis of familial chilblain lupus, systemic lupus erythematosus, and autosomal dominant retinal vas- culopathy with cerebral leukodystrophy [Lee-Kirsch et al., 2007a, b; Richards et al., 2007].”
Dysregulation of antiviral helicase pathways in systemic lupus erythematosus
Oliveira, L., Sinicato, N., Postal, M., Appenzeller, S., & Niewold, T. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00418 · Cited by 32
Genetics of migraine: an update with special attention to genetic comorbidity
Stam, A. H., van den Maagdenberg, A. M. J. M., Haan, J., Terwindt, G. M., & Ferrari, M. D. (2008) · Current Opinion in Neurology · doi:10.1097/wco.0b013e3282fd171a · Cited by 39
Brucet, M., Querol‐Audí, J., Bertlik, K., Lloberas, J., Fita, I., & Celada, A. (2008) · Protein Science · doi:10.1110/ps.036426.108 · Cited by 37
“…directly involved in a severe neurological brain disease, the Aicardi-Goutières syndrome (Crow et al. 2006), an autosomal dominant retinal vasculopathy with cerebral leukodystrophy (Richards et al. 2007), and is related to systemic lupus erythematosus (Lee-Kirsch et al. 2007a,b; Rice et al. 2007).”
BackgroundThe Role of Nucleic Acid Sensing in Controlling Microbial and Autoimmune Disorders
Matz, K. M., Guzman, R. M., & Goodman, A. G. (2018) · International review of cytology · doi:10.1016/bs.ircmb.2018.08.002 · Cited by 35
“Missense TREX1 mutations present in systemic lupus erythematosus patients (Lee-Kirsch et al., 2007) 1–3.”
BackgroundUpdate on the pathogenesis of central nervous system lupus
Nikolopoulos, D., Fanouriakis, A., & Boumpas, D. T. (2019) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000655 · Cited by 33
Soong, B., Liao, Y., Tu, P., Tsai, P., Lee, I., Chung, C., & Lee, Y. (2013) · Journal of the Chinese Medical Association · doi:10.1016/j.jcma.2013.03.002 · Cited by 35
Self-citationTesser, A., de Carvalho, L. M., Sandrin‐Garcia, P., Pin, A., Pastore, S., Taddio, A., Roberti, L. R., Queiróz, R. G. D. P., Ferriani, V. P. L., Crovella, S., et al. (2020) · Arthritis Research & Therapy · doi:10.1186/s13075-020-02161-8 · Cited by 33
Shi, W., Xu, G., Gao, Y. J., Yang, H., Liu, T., Jia, Z., Li, H., Wei, Z., Hou, X., Chen, Y., et al. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155404 · Cited by 36
Activation and regulation of cGAS-STING signaling in cancer cells
Shim, A., Chen, Y., & Maciejowski, J. (2025) · Molecular Cell · doi:10.1016/j.molcel.2025.08.030 · Cited by 37
Karageorgas, T., Tseronis, D. D., & Mavragani, C. P. (2011) · BioMed Research International · doi:10.1155/2011/273907 · Cited by 36
Connections between antiviral defense and autoimmunity
Stetson, D. B. (2009) · Current Opinion in Immunology · doi:10.1016/j.coi.2009.05.005 · Cited by 35
“Second, Trex1 mutations are found at higher frequency in SLE patients than in healthy controls [52].”
BackgroundBailey, S. L., Harvey, S. E., Perrino, F. W., & Hollis, T. (2011) · DNA repair · doi:10.1016/j.dnarep.2011.10.007 · Cited by 36
“The TREX1 protein also has an extended C-terminal region that is involved in the sub-cellular localization of TREX1 on the cytosolic side of the endoplasmic reticulum [3, 12].”
BackgroundSelf-citationDisulfiram ameliorates STING/MITA-dependent inflammation and autoimmunity by targeting RNF115
Zhang, Z.-D., Shi, C.-R., Li, F., Gan, H., Wei, Y., Zhang, Q., Shuai, X., Chen, M., Lin, Y., Xiong, T.-C., et al. (2024) · Cellular and Molecular Immunology · doi:10.1038/s41423-024-01131-3 · Cited by 34
“It has been shown that 1 – 2% of SLE patients carry TREX1 mutations that result in activation of the cGAS-cGAMP-STING axis [35, 36].”
Huang, K.-W., Hsu, K., Chu, L.-Y., Yang, J., Yuan, H. S., & Hsiao, Y.-Y. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00794 · Cited by 30
Secreted gelsolin desensitizes and induces apoptosis of infiltrated lymphocytes in prostate cancer
Chen, C.-C., Chiou, S.-H., Yang, C., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.20414 · Cited by 29
“Our study model also provides a reasonable explanation for translocation of ER membrane-integrated proteins (such as TREX1, a 3’ DNA repair exonuclease) to the nucleus [33, 34].”
BackgroundGonzález‐Serna, D., Ortiz‐Fernández, L., Vargas, S., García, A., Raya, E., Fernández‐Gutiérrez, B., López‐Longo, F. J., Balsa, A., González‐Álvaro, I., Narváez, J., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-26573-4 · Cited by 27
Self-citationBiology of RNA Surveillance in Development and Disease
Laffleur, B., & Basu, U. (2019) · Trends in Cell Biology · doi:10.1016/j.tcb.2019.01.004 · Cited by 32
“RNase H2 mutations are also linked to systemic lupus erythematosus (SLE) [100], and TREX1 deficiencies or mutations have also been implicated in both AGS [101] and SLE [102].”
BackgroundSafeguard against DNA sensing: the role of TREX1 in HIV-1 infection and autoimmune diseases
Hasan, M., & Yan, N. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2014.00193 · Cited by 35
“In contrast, TREX1 SLE mutations are mostly autosomal dominant, with two exceptions where compound heterozygous missense mutations were found (Lee-Kirsch et al., 2007).”
BackgroundInfluentialLupus: How much “complexity” is really (just) genetic heterogeneity?
Crow, Y. J. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30603 · Cited by 31
Therapeutic Approaches to Type I Interferonopathies
Bienias, M., Brück, N., Griep, C., Wolf, C., Kretschmer, S., Kind, B., Tüngler, V., Berner, R., & Lee‐Kirsch, M. A. (2018) · Current Rheumatology Reports · doi:10.1007/s11926-018-0743-3 · Cited by 30
Self-citationTargeting TREX1 Induces Innate Immune Response in Drug-Resistant Small-Cell Lung Cancer
Murayama, T., Mahadevan, N. R., Meador, C. B., Ivanova, E. V., Pan, Y., Knelson, E. H., Tani, T., Nakayama, J., Ma, X., Thai, T. C., et al. (2024) · Cancer Research Communications · doi:10.1158/2767-9764.crc-24-0360 · Cited by 32
Han, X. Q., Ma, G., Peng, R.-K., Ju, X., Sheng, L., Liu, H., Sui, Q., Li, J., Gu, Y., Yu, J., et al. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c02200 · Cited by 33
Shimada, A., Masui, R., Nakagawa, N., Takahata, Y., Kim, K., Kuramitsu, S., & Fukui, K. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq350 · Cited by 32
Teruel, M., Chamberlain, C., & Alarcón-Riquelme, M. E. (2016) · Rheumatology · doi:10.1093/rheumatology/kew339 · Cited by 35
Regulation of cGAS-STING pathway - Implications for systemic lupus erythematosus
Hagiwara, A. M., Moore, R. E., Wallace, D. J., ISHIMORI, M. L., & Jefferies, C. A. (2021) · Rheumatology and Immunology Research · doi:10.2478/rir-2021-0023 · Cited by 31
TREX1 As a Potential Therapeutic Target for Autoimmune and Inflammatory Diseases
Tao, S., Wu, G., Zhang, Q., Zhang, T., Leng, R., Pan, H., & Ye, D. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190902113218 · Cited by 28
T Cells Produce IFN-α in the TREX1 D18N Model of Lupus-like Autoimmunity
Simpson, S. R., Rego, S. L., Harvey, S. E., Liu, M., Hemphill, W. O., Venkatadri, R., Sharma, R., Grayson, J. M., & Perrino, F. W. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1900220 · Cited by 28
Self-citationIncreased Susceptibility to Skin Carcinogenesis in TREX2 Knockout Mice
Parra, D., Manils, J., Castellana, B., Viña‐Vilaseca, A., Morán‐Salvador, E., Vázquez‐Villoldo, N., Tarancón, G., Borràs, M., Sancho, S., Benito, C., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1208 · Cited by 32
Cheung, Y.-H., Loh, C., Pau, E., Kim, J. J., & Wither, J. (2009) · Seminars in Immunology · doi:10.1016/j.smim.2009.10.005 · Cited by 32
Monogenic systemic lupus erythematosus: insights in pathophysiology
Batu, E. D. (2018) · Rheumatology International · doi:10.1007/s00296-018-4048-7 · Cited by 34
Etiology and Pathogenesis of Systemic Lupus Erythematosus
Crow, M. K. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-31696-5.00079-6 · Cited by 31
O’Driscoll, M. (2008) · DNA repair · doi:10.1016/j.dnarep.2008.02.010 · Cited by 29
Li, L., Ye, Q., Ma, J., Wang, Z., Liu, T., Lei, Y., Lu, M., Kang, J., Xiang, H., Li, B., et al. (2026) · Cancer Cell · doi:10.1016/j.ccell.2025.12.013 · Cited by 33
Photosensitivity and cGAS-Dependent IFN-1 Activation in Patients with Lupus and TREX1 Deficiency
Berndt, N., Wolf, C., Fischer, K., Costa, E. C., Knuschke, P., Zimmermann, N., Schmidt, F., Merkel, M., Chara, O., Lee‐Kirsch, M. A., et al. (2021) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2021.04.037 · Cited by 27
Self-citationBehrendt, R., & Roers, A. (2013) · Clinical & Experimental Immunology · doi:10.1111/cei.12147 · Cited by 27
Prendiville, J., & Crow, Y. J. (2009) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2009.05.002 · Cited by 25
Xu, J., Zoltick, P. W., Gamero, A. M., & Gallucci, S. (2014) · Journal of Leukocyte Biology · doi:10.1189/jlb.2a0713-393rr · Cited by 30
“Although rare, Trex1 mutations are present in autoimmune diseases, such as familial chilblain lupus [21, 22] and SLE [23, 24].”
BackgroundExploring Autoimmunity in a Cohort of Children with Genetically Confirmed Aicardi–Goutières Syndrome
IAGSA study group, Cattalini, M., Galli, J., Andréoli, L., Olivieri, I., Ariaudo, G., Fredi, M., Orcesi, S., Tincani, A., & Fazzi, E. M. (2016) · Journal of Clinical Immunology · doi:10.1007/s10875-016-0325-y · Cited by 26
Insights Gained From the Study of Pediatric Systemic Lupus Erythematosus
Lo, M. S. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01278 · Cited by 27
“Further, heterozygous mutations in TREX1 have been described at a higher rate in SLE patients as compared to healthy controls, and one particular TREX1 haplotype has been associated with neurological manifestations in SLE (53, 54).”
BackgroundCrow, Y. J., Lebon, P., Casanova, J., & Gresser, I. (2018) · Journal of Clinical Immunology · doi:10.1007/s10875-018-0543-6 · Cited by 25
TREX1 variants in Sjogren's syndrome related lymphomagenesis
Nezos, A., Makri, P., Gandolfo, S., Vita, S. D., Voulgarelis, M., Crow, M. K., & Mavragani, C. P. (2019) · Cytokine · doi:10.1016/j.cyto.2019.154781 · Cited by 27
Banka, S., Cain, S. A., Carim, S. C., Daly, S. B., Urquhart, J. E., Erdem, G., Harris, J., Bottomley, M., Donnai, D., Kerr, B. A., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204309 · Cited by 25
Sui, W., Tan, Q., Yang, M. W., Yan, Q., LIN, H., Ou, M., XUE, W., Chen, J., ZOU, T., Jing, H., et al. (2015) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2015.2149 · Cited by 26
“Rare mutations in the TREX1 gene, the major mammalian 3'-5' exonuclease, have been reported in sporadic SLE cases (20,21).”
TREX1 plays multiple roles in human diseases
Wang, Q., Du, J., Hua, S., & Zhao, K. (2022) · Cellular Immunology · doi:10.1016/j.cellimm.2022.104527 · Cited by 31
Cytoplasmic DNA in cancer cells: Several pathways that potentially limit DNase2 and TREX1 activities
Anindya, R. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2022.119278 · Cited by 26
Aicardi–Goutières syndrome: clues from the RNase H2 knock-out mouse
Rabe, B. (2013) · Journal of Molecular Medicine · doi:10.1007/s00109-013-1061-x · Cited by 30
Linking retroelements to autoimmunity.
Bhoj, V. G., & Chen, Z.-J. J. (2008) · Cell · doi:10.1016/j.cell.2008.08.010 · Cited by 25
“Recent studies have also identified mutations in Trex1 that are associated with systemic lupus erythematosus (Lee-Kirsch et al., 2007).”
BackgroundLupus pathobiology based on genomics
Saeed, M. (2016) · Immunogenetics · doi:10.1007/s00251-016-0961-7 · Cited by 26
Tsubata, T. (2019) · Immune Network · doi:10.4110/in.2019.19.e1 · Cited by 29
“Various rare mutations in TREX1 are found in 1%–2% of SLE patients (28,29), suggesting a role of TREX1 mutation in development”
BackgroundFermaintt, C. S., Sano, K., Liu, Z., Ishii, N., Seino, J., Dobbs, N., Suzuki, T., Fu, Y., Lehrman, M. A., Matsuo, I., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10319-5 · Cited by 26
Epilepsy in Aicardi–Goutières syndrome
Ramantani, G., Maillard, L. G., Bast, T., Husain, R. A., Niggemann, P., Kohlhase, J., Hertzberg, C., Ungerath, K., Innes, A. M., Walkenhorst, H., et al. (2013) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2013.07.005 · Cited by 23
Self-citationA TREX1 mutation causing cerebral vasculopathy in a patient with familial chilblain lupus
Yamashiro, K., Tanaka, R., Li, Y., Mikasa, M., & Hattori, N. (2013) · Journal of Neurology · doi:10.1007/s00415-013-7084-y · Cited by 24
Current concepts of photosensitivity in cutaneous lupus erythematosus
Klein, B., & Kunz, M. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.939594 · Cited by 27
Chiche, L., Jourde‐Chiche, N., Pascual, V., & Chaussabel, D. (2013) · Arthritis & Rheumatism · doi:10.1002/art.37909 · Cited by 23
Characterization of Trex1 Induction by IFN-γ in Murine Macrophages
Serra, M., Forcales, S. V., Pereira‐Lopes, S., Lloberas, J., & Celada, A. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002364 · Cited by 30
Bridging the gap between autoinflammation and autoimmunity
Hedrich, C. M., & Tsokos, G. C. (2013) · Clinical Immunology · doi:10.1016/j.clim.2013.03.006 · Cited by 23
Role of Extrachromosomal Histone H2B on Recognition of DNA Viruses and Cell Damage
Kobiyama, K., Kawashima, A., Jounai, N., Takeshita, F., Ishii, K. J., Ito, T., & Suzuki, K. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2013.00091 · Cited by 27
“…mutations of DNase I and DNase III in humans have also been associated with several autoimmune disorders, such as SLE (Yasutomo et al., 2001; Lee-Kirsch et al., 2007b), Aicardi–Goutieres syndrome (Crow et al., 2006), familial chilblain lupus (Lee-Kirsch et al., 2007a), and retinal…”
BackgroundTREX1 Mutation Causing Autosomal Dominant Thrombotic Microangiopathy and CKD—A Novel Presentation
Gulati, A., Bale, A. E., Dykas, D. J., BIA, M. J., Danovitch, G. M., Moeckel, G. W., Somlo, S., & Dahl, N. K. (2018) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2018.05.006 · Cited by 26
Ornstein, B. W., Atkinson, J. P., & Densen, P. (2012) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e328356896b · Cited by 23
Non–Interferon-Dependent Role of STING Signaling in Pulmonary Hypertension
Pham, A. T., de Oliveira, A. C., Fu, C., Alves, M. D., Dupee, Z., Mukhsinova, L., Ebrahimi, E., Patel, H., Patel, R., Nguyen, A., et al. (2023) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.123.320121 · Cited by 22
Sugiura, K., Takeichi, T., Kono, M., Ito, Y., Ogawa, Y., Muro, Y., & Akiyama, M. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.210 · Cited by 22
The prototypical interferonopathy: Aicardi‐Goutières syndrome from bedside to bench
Hofer, M. J., Modesti, N. B., Coufal, N. G., Wang, Q., Sase, S., Miner, J. J., Vanderver, A. L., & Bennett, M. L. (2024) · Immunological Reviews · doi:10.1111/imr.13413 · Cited by 26
“Patients with heterozygous pathogenic mutations in TREX1 can present with systemic lupus erythematosus, familial chil-blain lupus, and cryofibrinogenemia, 89,90 including variants also seen in individuals affected by AGS.”
Animal models of leukodystrophy: a new perspective for the development of therapies
Rutherford, H. A., & Hamilton, N. (2019) · FEBS Journal · doi:10.1111/febs.15060 · Cited by 23
Lee, W.-F., Fan, W., Tseng, M., Yang, H., Huang, J., & Wu, C. (2022) · Pediatric Rheumatology · doi:10.1186/s12969-022-00722-6 · Cited by 25
“Worthwhile to mention, while the clinical features of heterozygous TREX1 mutations have been described in patients with lupus [34, 35], the identification of homozygous TREX1 (c.”
BackgroundDu, Y., Zhang, H., Nie, X., Qi, Y., Shi, S., Han, Y., Zhou, W., He, C., & Wang, L. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.965726 · Cited by 23
Pathophysiological Roles of the cGAS-STING Inflammatory Pathway
Maekawa, H., Fain, M. E., & Wasano, K. (2023) · Physiology · doi:10.1152/physiol.00031.2022 · Cited by 24
Closing the gap between genotype and phenotype
Gregersen, P. K. (2009) · Nature Genetics · doi:10.1038/ng0909-958 · Cited by 28
Nucleic acid metabolism and systemic autoimmunity revisited
Lee‐Kirsch, M. A. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27372 · Cited by 22
“Moreover, heterozygous TREX1 mutations are found in 2–3% of patients with systemic lupus erythematosus (10).”
BackgroundSelf-citationCellular and Molecular Mechanisms of Autoimmunity and Lupus Nephritis
Devarapu, S. K., Lorenz, G., Kulkarni, O. P., Anders, H., & Mulay, S. R. (2017) · International review of cytology · doi:10.1016/bs.ircmb.2016.12.001 · Cited by 21
Bartsch, K., Damme, M., Regen, T., Becker, L., Garrett, L., Hölter, S. M., Knittler, K., Borowski, C., Waisman, A., Glatzel, M., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00587 · Cited by 20
Cytosolic sensing of aberrant DNA: arming STING on the endoplasmic reticulum
Wang, Q., Liu, X., Zhou, Q., & Wang, C. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2015.1067303 · Cited by 22
“Conversely, inappropriate provocation of the immune system by aberrant self-DNA, which should be cleared under normal conditions, is involved in the pathogenesis of certain autoimmune diseases, such as systemic lupus erythematosus (SLE), lupus-like diseases and Aicardi Goutieres 10.1517/14728222.2015.1067303 © 2015 In…”
BackgroundInfluentialExonucleases: Degrading DNA to Deal with Genome Damage, Cell Death, Inflammation and Cancer
Manils, J., Marruecos, L., & Soler, C. (2022) · Cells · doi:10.3390/cells11142157 · Cited by 24
Rego, S. L., Harvey, S. E., Simpson, S. R., Hemphill, W. O., McIver, Z. A., Grayson, J. M., & Perrino, F. W. (2018) · Autoimmunity · doi:10.1080/08916934.2018.1522305 · Cited by 21
Self-citationPlatelet-derived Growth Factor Receptor Alpha Gene Mutations in Vitiligo Vulgaris
Xu, S., Zhou, Y., Yang, S., Ren, Y., Zhang, C., Quan, C., Gao, M., He, C., Chen, H., Hhan, J., et al. (2010) · Acta Dermato Venereologica · doi:10.2340/00015555-0820 · Cited by 23
Cutaneous histopathology of lupus erythematosus
CROWSON, A. N., & MAGRO, C. M. J. (2009) · Diagnostic histopathology · doi:10.1016/j.mpdhp.2009.02.006 · Cited by 21
Rare variants, autoimmune disease, and arthritis
Chung, S. A., & Shum, A. K. (2016) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000298 · Cited by 21
“[46] investigated whether TREX1 mutations were also associated with SLE.”
BackgroundMollah, Z. U. A., Quah, H. S., Graham, K. L., Jhala, G., Krishnamurthy, B., Dharma, M., Chee, J., Trivedi, P., Pappas, E. G., Mackin, L., et al. (2017) · Diabetes · doi:10.2337/db17-0517 · Cited by 18
Nemer, G. M., El-Hachem, N., Eid, E. S., Hamie, L., Bardawil, T., Khalil, S., El‐Rassy, I., Safi, R., Khalil, A., Abbas, O. M., et al. (2020) · Clinical Genetics · doi:10.1111/cge.13767 · Cited by 22
González‐Quintial, R., Nguyen, A., Kono, D. H., Oldstone, M. B. A., Theofilopoulos, A. N., & Baccalà, R. (2018) · PLoS ONE · doi:10.1371/journal.pone.0203118 · Cited by 19
Chromatin bridges: stochastic breakage or regulated resolution?
Jiang, H., & Chan, Y. W. (2023) · Trends in Genetics · doi:10.1016/j.tig.2023.10.004 · Cited by 24
Metadata
- Authors
- Lee-Kirsch, M. A., Gong, M., Chowdhury, D., Senenko, L., Engel, K., Lee, Y.-A., de Silva, U., Bailey, S. L., Witte, T., Vyse, T. J., Kere, J., Pfeiffer, C., Harvey, S., Wong, A., Koskenmies, S., Hummel, O., Rohde, K., Schmidt, R. E., Dominiczak, A. F., Gahr, M., Hollis, T., Perrino, F. W., Lieberman, J., & Hübner, N.
- Affiliations
- Max Delbrück Center (DE)
- Harvard University (US)
- Technische Universität Dresden (DE)
- Wake Forest University Health Sciences (US)
- Medizinische Hochschule Hannover (DE)
- Hammersmith Hospital (GB)
- Karolinska Institutet (SE)
- Klinik und Poliklinik für Dermatologie (DE)
- University of Helsinki (FI)
- University of Glasgow (GB)
- Corresponding author
- Lee, Young-Ae
- Hübner, Norbert
- ORCID
- Venue
- Nature Genetics
- Published
- 2007-07-29
- Volume
- 39
- Issue
- 9
- Pages
- 1065-1067
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2043959346
- Semantic Scholar
- 443992a86650d6f5f9c909d94b91ccce78822316
- Cited by
- 730
- References
- 15
- Citations by year
- 2026: 21 · 2025: 31 · 2024: 57 · 2023: 32 · 2022: 30 · 2021: 36 · 2020: 23 · 2019: 44 · 2018: 34 · 2017: 39 · 2016: 48 · 2015: 43 · 2014: 38 · 2013: 57 · 2012: 48
- FWCI
- 25.37
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (submittedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- National Institute of General Medical Sciences (R01GM069962, GM 069962)
- National Institute of Allergy and Infectious Diseases (AI45587)
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Keywords
- TREX1, systemic lupus erythematosus, 3'-5' exonuclease, Aicardi-Goutières syndrome, monoallelic variants, frameshift mutation, missense mutations, 3'UTR variant, subcellular targeting, genetic susceptibility
- MeSH terms
- Exodeoxyribonucleases, Gene Frequency, Genotype, HeLa Cells, Humans, Lupus Erythematosus, Cutaneous, Mutation, Phosphoproteins, Endosomes, Recombinant Proteins, Frameshift Mutation, Protein Structure, Tertiary, Genetic Predisposition to Disease, Mutation, Missense, 3' Untranslated Regions, Green Fluorescent Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.